Cargando…

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients

Detalles Bibliográficos
Autores principales:	Badaoui, L, Dabo, G, Lamdini, H, Bensghir, R, Lahsen, A Oulad, Sodqi, M, Marih, L, Chakib, A, El Filali, K Marhoum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220944/ http://dx.doi.org/10.1186/1471-2334-14-S2-P49

Ejemplares similares

Prevalence of hepatitis C virus infection among HIV-infected people in Casablanca
por: Badaoui, L, et al.
Publicado: (2014)

Intestinal cryptosporidiosis in HIV-infected patients in the department of infectious diseases
por: Badoui, L, et al.
Publicado: (2014)

TP53 R72P Polymorphism and Susceptibility to Human Papillomavirus Infection Among Women With Human Immunodeficiency Virus in Morocco: A Case-control Study
por: Lahsen, Ahd Oulad, et al.
Publicado: (2017)

Missed opportunities for HIV testing in patients newly diagnosed with HIV in Morocco
por: Marih, Latifa, et al.
Publicado: (2021)

Current clinico-mycological trends of onychopathies in Casablanca
por: Badaoui, L, et al.
Publicado: (2014)

Opportunistic digestive parasitic infections in adults infected with HIV: epidemiological expression
por: Badaoui, L, et al.
Publicado: (2014)

Nevirapine-associated liver toxicity and hypersensitivity reactions in a cohort of HIV-1-infected patients,clinical analysis
por: Jonckheere, Sylvie, et al.
Publicado: (2012)

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)
por: Arastéh, K, et al.
Publicado: (2010)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

PReS-FINAL-2201: A P268S NOD mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Spectrum of adverse cutaneous eruptions to nevirapine – a cross sectional study
por: Budamakuntla, Leelavathy, et al.
Publicado: (2012)

Auto immune haemolytic anaemia as part of Nevirapine induced DRESS syndrome
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

Role of the general base Glu268 in nitroglycerin bioactivation and mechanism-based superoxide formation by aldehyde dehydrogenase-2
por: Wenzl, M Verena, et al.
Publicado: (2009)

Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008
por: Bruyand, M, et al.
Publicado: (2010)

Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral treatment amongst an adult treatment cohort from South Africa
por: Bock, P, et al.
Publicado: (2010)

Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
por: DeJesus, E, et al.
Publicado: (2010)

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years
por: Podzamczer, D, et al.
Publicado: (2010)

Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
por: Rodriguez, JM, et al.
Publicado: (2010)

Assessment of two POC technologies for CD4 count in Morocco
por: Elharti, Elmir, et al.
Publicado: (2020)

P268: One-day prevalence survey of hospital acquired infections at the hospital of the mother and child lagoon in Cotonou Benin Homel, March 2012
por: Batossi, G
Publicado: (2013)

A268 RESOLUTION RATES IN OPEN-LABEL VERSUS RANDOMIZED CONTROLLED TRIALS FOR MICROBIOTA RESTORATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: AN UPDATED META-ANALYSIS
por: Tariq, R, et al.
Publicado: (2023)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Changing incidence of nevirapine-induced cutaneous drug reactions: After revised guideline Nov 2011
por: Lokhande, Archana J, et al.
Publicado: (2013)

Cutaneous anaplastic large cell lymphoma in HIV exceptional case in Algeria
por: Rais, M, et al.
Publicado: (2014)

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014)

A severe cutaneous reaction caused by acetaminophen in a pediatric patient
por: Schroeder, Jan, et al.
Publicado: (2014)

HLA involvement in nevirapine-induced dermatological reaction in antiretroviral-treated HIV-1 patients
por: Umapathy, Shankarkumar, et al.
Publicado: (2011)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
por: Hu, H, et al.
Publicado: (2012)

Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
por: Bellón, Teresa, et al.
Publicado: (2014)

P268 Laryngeal Mucormycosis: does mucor take the voice away?
por: Rege, Sujata, et al.
Publicado: (2022)

Cutaneous mucormycosis in the ICU
por: Herrero, EH, et al.
Publicado: (2015)

An immunohistochemical study of the granulysin expression of 6 types of proven adverse cutaneous drug reaction
por: Weinborn, Marie, et al.
Publicado: (2014)

Pulmonary, ocular and cutaneous Kaposi sarcoma in a HIV-infected patient
por: Ionică, Mihaela, et al.
Publicado: (2014)

When the skin speaks what HIV dictates: a series of particular cases of cutaneous manifestations in HIV
por: Răducan, Anca, et al.
Publicado: (2014)

268. Methicillin Sensitive Versus Methicillin Resistant Staphylococcus aureus Nosocomial Meningitis
por: Akyol, Deniz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9mn04p7mtfl85g7e9632gjcgg6